BRAIN CANCER

This study tested a drug called VAL-083, given alongside standard radiation therapy, for people newly diagnosed with an aggressive brain cancer called glioblastoma (GBM). It focused on patients whose tumors have a specific genetic feature (unmethylated MGMT) that makes them less …

This study tested a new type of MRI contrast dye called RVP-001, which is based on manganese instead of the commonly used gadolinium. It involved 18 adults with known brain or spinal cord lesions from conditions like tumors or multiple sclerosis. The main goal was to see if RVP-0…

This small, early-stage study tested a new type of combined PET and MRI scan to see if it could take clearer pictures of brain tumors. It involved 5 adult patients with new or suspected returning brain tumors who were already scheduled for treatment. The goal was to gather initia…

This study tested a special talk therapy program called CALM, designed to help people with advanced brain cancer cope with emotional distress, depression, and anxiety about death. It compared the CALM program to the usual care patients receive. The main goal was to see if the the…

This study tested a new brain training program designed to help people who have survived brain cancer but are struggling with memory, thinking, or behavior changes. The program involved both the patient and a family caregiver to help practice new skills at home. Researchers wante…

This study tested whether a digital support program and a dedicated guide could help family caregivers of brain cancer patients feel less stressed, anxious, and burdened. It involved nearly 300 caregivers and their patients. The goal was to see if this support system improved the…

This study aimed to better understand brain and spinal cord tumors by observing over 1,200 adult patients over time. Researchers collected medical information, scans, and tissue samples to learn how these cancers progress and to identify areas for future treatment research. The s…